Thermoforming technology specialist Nelipak Healthcare Packaging (Venray, Netherlands) and vision inspection systems company Optel Group (Québec, QC, Canada) have entered into an agreement of intent to explore commercial opportunities for a new seal inspection technology for the medical device market.
Packaging seal integrity is paramount to maintaining the sterility of packaged medical products. Optel and Nelipak are pursuing commercialization of a technology that will allow real-time verification of seal quality while detecting contaminants and other anomalies such as creases. The process will take only seconds, minimizing impact on production and overall equipment effectiveness data, while eliminating the risk of human error during visual inspection.
“Foreign-body contaminants or poorly sealed vacuum-formed trays can create major setbacks for getting a product to market or cause time-consuming and costly product recalls,” said Michael Butler, Senior Account Director at Optel. “The market stands to benefit significantly from a more precise and consistent method of inspecting and validating seal quality using algorithms preconfigured to a company’s exact specifications.”
“We are solely focused on understanding the specific needs and stringent requirements of the healthcare packaging market in the design and manufacture of rigid trays sealed on Nelipak heat tray sealers and other platforms,” said Seán Egan, Director of Global Marketing at Nelipak. “We’re pleased to apply our deep understanding of sealing processes and challenges to working with Optel to bring to market a highly efficient and effective way to ensure seal quality.”
Both companies will exhibit at MedtecLIVE on May 21 to 23, 2019, in Nuremberg, Germany.